Summary
Commonly reported side effects of valbenazine include: drowsiness, fatigue, and sedated state. Continue reading for a comprehensive list of adverse effects.
Applies to valbenazine: oral capsules.
Side effects include:
Adverse effects occurring in ≥2% of patients receiving valbenazine in short-term tardive dyskinesia clinical trials and at a higher frequency than reported with placebo include somnolence (including fatigue and sedation), anticholinergic effects (including dry mouth, constipation, attention disturbance, blurred vision, and urinary retention), balance disorders (including falls, gait disturbances, and dizziness), headache, akathisia/restlessness, vomiting, nausea, and arthralgia.
For Healthcare Professionals
Applies to valbenazine: oral capsule.
General
-The most common adverse reaction (5% or more and twice the rate of placebo) was somnolence.
-A total of 3% of patients discontinued treatment because of adverse reactions.[Ref]
Nervous system
Very common (10% or more): Somnolence/fatigue/sedation (10.9%)
Common (1% to 10%): Anticholinergic effects (dry mouth, constipation, attention disturbance, blurred vision, urinary retention), balance disorders/fall/gait disturbance/dizziness, headache, akathisia/restlessness, drooling, dyskinesia,
non-akathisia extrapyramidal symptoms[Ref]
Gastrointestinal
Common (1% to 10%): Vomiting, nausea[Ref]
Hepatic
Common (1% to 10%): Increased alkaline phosphatase and bilirubin[Ref]
Metabolic
Common (1% to 10%): Increased blood glucose, increased weight, increased prolactin[Ref]
Musculoskeletal
Common (1% to 10%): Arthralgia[Ref]
Psychiatric
Common (1% to 10%): Anxiety, insomnia[Ref]
Respiratory
Common (1% to 10%): Respiratory infections[Ref]